Cited by 4,649Cancer-related Molecular PathwaysDevelopmental Biology and Gene RegulationCell death mechanisms and regulation

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

Donehower, Lawrence A., Harvey, Michele, Slagle, Betty L., McArthur, Mark J., Montgomery, Charles A., Butel, Janet S., Bradley, Allan·1992·Nature

DOI 10.1038/356215a0

Open this paper in CoChat — free account

Abstract

Mutations in the p53 tumour-suppressor gene are the most frequently observed genetic lesions in human cancers. To investigate the role of the p53 gene in mammalian development and tumorigenesis, a null mutation was introduced into the gene by homologous recombination in murine embryonic stem cells. Mice homozygous for the null allele appear normal but are prone to the spontaneous development of a variety of neoplasms by 6 months of age. These observations indicate that a normal p53 gene is dispensable for embryonic development, that its absence predisposes the animal to neoplastic disease, and that an oncogenic mutant form of p53 is not obligatory for the genesis of many types of tumours.

Integrity signals

Registry

Crossref · 10.1038/356215a0

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
The p53 tumour suppressor gene
Levine, A. J., Momand, J. A., & Finlay, C. A. (1991) · Nature · doi:10.1038/351453a0 · Cited by 3,785
Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other Neoplasms
Malkin, D., Li, F. P., Strong, L. C., Fraumeni, J. F., Nelson, C. E., Kim, D. H., Kassel, J., Gryka, M. A., Bischoff, F. Z., Tainsky, M. A., et al. (1990) · Science · doi:10.1126/science.1978757 · Cited by 3,765
Association of Human Papillomavirus Types 16 and 18 E6 Proteins with p53
Werness, B. A., Levine, A. J., & Howley, P. M. (1990) · Science · doi:10.1126/science.2157286 · Cited by 2,562
T antigen is bound to a host protein in SY40-transformed cells
Lane, D. P., & Crawford, L. V. (1979) · Nature · doi:10.1038/278261a0 · Cited by 2,456
Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice
Soriano, P. M., Montgomery, C. A., Geske, R. S., & Bradley, A. (1991) · Cell · doi:10.1016/0092-8674(91)90499-o · Cited by 1,997
Self-citation
The p53 proto-oncogene can act as a suppressor of transformation
Finlay, C. A., Hinds, P. W., & Levine, A. J. (1989) · Cell · doi:10.1016/0092-8674(89)90045-7 · Cited by 1,987
Characterization of a 54K Dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells
Linzer, D. I. H., & Levine, A. J. (1979) · Cell · doi:10.1016/0092-8674(79)90293-9 · Cited by 1,814
Suppression of Human Colorectal Carcinoma Cell Growth by Wild-Type p53
Baker, S. J., Markowitz, S. D., Fearon, E. R., Willson, J. K. V., & Vogelstein, B. (1990) · Science · doi:10.1126/science.2144057 · Cited by 1,742
Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: A general strategy for targeting mutations to non-selectable genes
Mansour, S. L., Thomas, K. R., & Capecchi, M. R. (1988) · Nature · doi:10.1038/336348a0 · Cited by 1,683

Flagged first, then by citations

Show all 48 references

Research works printed but not linked: 10

Mowat, M., Cheng, A., Kicumca, N., Bernstein, A. & Benchimol, S. Nature 61, 2777–2781 (1985).
Ben David, Y., Prideaux, V. R., Chow, V., Benchimol, S. & Bernstein, A. Oncogene 3, 179–185 (1988).
Stürzbecher, H.-W. et al. Oncogene 5, 795–801 (1990).
Shaulsky, G., Ben-Ze'ev, A. & Rotter, V. Oncogene 5, 1707–1711 (1990).
Soussi, T., de Fromentel, C. C. & May, P. Oncogene 5, 945–952 (1990).
Bradley, A. in Tetratocarcinomas and Embryonic Stem Cells: A Practical Approach (ed. Robertson, E. J.) 113–151 (IRL, Oxford, 1987).
Stutman, O. Fed. Proc. Fed. Am. Soc. exp. Biol. 33, 2028–2032 (1974).
Yandell, D. W. Proc. Am. Assoc. Cancer Res. 32, 459–460 (1991).
Sepulveda, A. R. et al. Cancer Res. 49, 6108–6117 (1989).
Slagle, B. L., Lanford, R. E., Medina, D. & Butel, J. S. Cancer Res. 42, 2155–2162 (1984).

Sorted by citations

Items 601–700 of 1,032

Suppression of tumorigenesis by the p53 target PUMA
Hemann, M. T., Zilfou, J. T., Zhao, Z., Burgess, D. J., Hannon, G. J., & Lowe, S. W. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403286101 · Cited by 183
IL-4, but not vitamin D3, induces monoblastic cell line UG3 to differentiate into multinucleated giant cells on osteoclast lineage
Kaji, Y., Ikeda, K., Ikeda, T., Kawakami, K., Sasaki, K., Shindo, M., Hatake, K., Harada, M., Motoyoshi, K., Mori, S., et al. (2000) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(200002)182:2 · Cited by 10
Abnormal development of Purkinje cells and lymphocytes in Atm mutant mice
Borghesani, P. R., Alt, F. W., Bottaro, A., Davidson, L., Aksoy, S., Rathbun, G. A., Roberts, T. M., Swat, W., Segal, R. A., & Gu, Y. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3336 · Cited by 183
The prognostic value of TP53 and its correlation with EGFR mutation in advanced non-small cell lung cancer, an analysis based on cBioPortal data base
Jiao, X., Qin, B., You, P., Cai, J. Q., & Zang, Y. (2018) · Lung Cancer · doi:10.1016/j.lungcan.2018.07.003 · Cited by 182
No PUMA, no death
Yu, J., & Zhang, L. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00249-6 · Cited by 182
Mice with reduced levels of p53 protein exhibit the testicular giant-cell degenerative syndrome.
Rotter, V., Schwartz, D., Almon, E. B., Goldfinger, N., Kapon, A., Meshorer, A., Donehower, L. A., & Levine, A. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.19.9075 · Cited by 182
Self-citation
The p53 tumor suppressor gene frequently is altered in gynecologic cancers
Berchuck, A., Kohler, M. F., Marks, J. R., Wiseman, R. W., Boyd, J. A., & Bast, R. C. (1994) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(94)70414-7 · Cited by 182
Apoptosis and carcinogenesis
Lyons, S. K., & Clarke, A. R. (1997) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a011630 · Cited by 182
c-Myc trans-activates the p53 promoter through a required downstream CACGTG motif.
Reisman, D., Elkind, N. B., Roy, B., Beamon, J., & Rotter, V. (1993) · PubMed · Cited by 182
Senescence Regulation by the p53 Protein Family
Qian, Y., & Chen, X. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-239-1_3 · Cited by 181
The role of the bcl-2/ced-9 gene family in cancer and general implications of defects in cell death control for tumourigenesis and resistance to chemotherapy
Strasser, A., Huang, D. C. S., & Vaux, D. L. (1997) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(97)00019-x · Cited by 181
Zebrafish Models for Cancer
Liu, S., & Leach, S. D. (2011) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130330 · Cited by 180
Loss of miRNA biogenesis induces p19Arf-p53 signaling and senescence in primary cells
Mudhasani, R., Zhu, Z., Hutvágner, G., Eischen, C. M., Lyle, S. R., Hall, L. L., Lawrence, J. B., Imbalzano, A. N., & Jones, S. N. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200802105 · Cited by 180
Functional overlap between murine Inpp5b and Ocrl1 may explain why deficiency of the murine ortholog for OCRL1 does not cause Lowe syndrome in mice.
Janne, P. A., Suchy, S. F., Bernard, D. J., MacDonald, M., Crawley, J. N., Grinberg, A., Wynshaw-Boris, A. J., Westphal, H., & Nussbaum, R. L. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2414 · Cited by 180
Mouse models of colorectal cancer: Past, present and future perspectives
Bürtin, F., Mullins, C. S., & Linnebacher, M. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i13.1394 · Cited by 183
Large-Scale Mutagenesis in p19ARF- and p53-Deficient Mice Identifies Cancer Genes and Their Collaborative Networks
Uren, A. G., Kool, J., Matentzoglu, K., de Ridder, J., Mattison, J., van Uitert, M., Lagcher, W., Sie, D., Tanger, E., Cox, T., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.021 · Cited by 179
DNA repair processes are critical mediators of p53-dependent tumor suppression
Janic, A., Valente, L. J., Wakefield, M. J., Stefano, L. D., Milla, L., Wilcox, S., Yang, H., Tai, L., Vandenberg, C. J., Kueh, A. J., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0043-5 · Cited by 179
Orthotopic Microinjection of Human Colon Cancer Cells in Nude Mice Induces Tumor Foci in All Clinically Relevant Metastatic Sites
Céspedes, M. V., Espina, C., García‐Cabezas, M. Á., Trías, M., Boluda, A., del Pulgar, M. T. G., Sancho, F. J., Nistal, M., Lacal, J. C., & Mangues, R. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.060773 · Cited by 178
Early Growth Response-1-dependent Apoptosis Is Mediated by p53
Nair, P., Muthukkumar, S., Sells, S. F., Han, S., Sukhatme, V. P., & Rangnekar, V. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.32.20131 · Cited by 177
TP53Mutations in Breast and Ovarian CancerPreprint
Silwal‐Pandit, L., Langerød, A., & Børresen‐Dale, A. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026252 · Cited by 177
p53 protects against skin cancer induction by UV-B radiation
Jiang, W., Ananthaswamy, H. N., Muller, H. K., & Kripke, M. L. (1999) · Oncogene · doi:10.1038/sj.onc.1202789 · Cited by 176
The Chromosomal Basis of Cancer
DUESBERG, P. H., Li, R., Fabarius, A. C., & Hehlmann, R. (2005) · Analytical Cellular Pathology · doi:10.1155/2005/951598 · Cited by 176
Essential role of p53 in phenethyl isothiocyanate-induced apoptosis.
Huang, C., Ma, W., Li, J., Hecht, S. S., & Dong, Z. (1998) · PubMed · Cited by 176
Cell cycle regulation by the retinoblastoma family of growth inhibitory proteins
Beijersbergen, R. L., & Bernards, R. (1996) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(96)00002-9 · Cited by 176
Functional interactions between p53 and the TFIIH complex are affected by tumour‐associated mutations.
Léveillard, T., Anděra, L., Bissonnette, N., Schaeffer, L., Bracco, L. P., Egly, J., & Wasylyk, B. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00506.x · Cited by 176
Reduced Mcm2 Expression Results in Severe Stem/Progenitor Cell Deficiency and Cancer
Pruitt, S. C., Bailey, K. J., & Freeland, A. L. (2007) · Stem Cells · doi:10.1634/stemcells.2007-0483 · Cited by 175
Biological and clinical importance of the p53 tumor suppressor gene
Velculescu, V. E., & El‐Deiry, W. S. (1996) · Clinical Chemistry · doi:10.1093/clinchem/42.6.858 · Cited by 175
Bcl-2 and p53 Protein Expression, Apoptosis, and p53 Mutation in Human Epithelial Ovarian Cancers
Chan, W. Y., Cheung, K., Schorge, J. O., Huang, L., Welch, W. R., Bell, D. A., Berkowitz, R. S., & Mok, S. C. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64744-x · Cited by 175
The role of p53 in neuronal cell death
Morrison, R. S., & Kinoshita, Y. (2000) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400741 · Cited by 175
p53 loss promotes acute myeloid leukemia by enabling aberrant self-renewalPreprint
Zhao, Z., Zuber, J. A., Díaz-Flores, E., Lintault, L., Kogan, S. C., Shannon, K., & Lowe, S. W. (2010) · Genes & Development · doi:10.1101/gad.1940710 · Cited by 175
The p53 Family Member Genes Are Involved in the Notch Signal Pathway
Sasaki, Y., Ishida, S., Morimoto, I., Yamashita, T., Kojima, T., Kihara, C., Tanaka, T., Imai, K., Nakamura, Y., & Tokino, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108080200 · Cited by 174
Apoptosis Overview Emphasizing the Role of Oxidative Stress, DNA Damage and Signal- Transduction Pathways
Payne, C. M., Bernstein, C., & Bernstein, H. (1995) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199509059662 · Cited by 174
The Role ofP53andMDM2Polymorphisms in the Risk of Esophageal Squamous Cell Carcinoma
Yuan, H., Miao, X., Zhang, X., Ding, F., Luo, A., Guo, Y., Tan, W., Liu, Z., & Lin, D. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1460 · Cited by 173
Up-regulation of inducible nitric oxide synthase expression in cancer-prone p53 knockout mice
Ambs, S., Ogunfusika, M. O., Merriam, W. G., Bennett, W. P., Billiar, T. R., & Harris, C. C. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8823 · Cited by 173
Solution structure of a conserved C‐terminal domain of p73 with structural homology to the SAM domain
Chi, S.-W., Ayed, A., & Arrowsmith, C. H. (1999) · The EMBO Journal · doi:10.1093/emboj/18.16.4438 · Cited by 173
Gene transfer of human heme oxygenase into coronary endothelial cells potentially promotes angiogenesis
Deramaudt, B. M. J. ‐., Braunstein, S. E., Rémy, P., & Abraham, N. G. (1998) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19980101)68:1 · Cited by 215
Macrophage p53 Deficiency Leads to Enhanced Atherosclerosis in APOE*3-Leiden Transgenic Mice
van Vlijmen, B. J. M., Gerritsen, G., Franken, A. L., Boesten, L. S. M., Kockx, M. M., Gijbels, M. J., Vierboom, M., Eck, M. V., van de Water, B., van Berkel, T. J. C., et al. (2001) · Circulation Research · doi:10.1161/hh0801.089261 · Cited by 173
Real-time in vivo imaging of p16Ink4a reveals cross talk with p53
Yamakoshi, K., Takahashi, A., Hirota, F., Nakayama, R., Ishimaru, N., Kubo, Y., Mann, D. J., Ohmura, M., Hirao, A., Saya, H., et al. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200904105 · Cited by 172
The role of DNA damage responses in p53 biology
Speidel, D. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1459-z · Cited by 172
BH3-only proteins in cell death initiation, malignant disease and anticancer therapy
Labi, V., Erlacher, M., Kießling, S., & Villunger, A. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401940 · Cited by 172
The emerging role of alternative splicing in senescence and aging
Deschênes, M., & Chabot, B. (2017) · Aging Cell · doi:10.1111/acel.12646 · Cited by 172
MicroRNAs in cancer cell death pathways: Apoptosis and necroptosis
Shirjang, S., Mansoori, B., Asghari, S., Duijf, P. H. G., Mohammadi, A., Gjerstorff, M. F., & Baradaran, B. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.05.017 · Cited by 172
Hepatoprotective effect of plant polysaccharides from natural resources: A review of the mechanisms and structure-activity relationship
Qu, J., Huang, P., Zhang, L., Qiu, Y., Qi, H., Leng, A., & Shang, D. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.05.196 · Cited by 172
Use of genetic suppressor elements to dissect distinct biological effects of separate p53 domains.
Ossovskaya, V., Mazo, I. A., Chernov, M. V., Chernova, O. B., Strezoska, Ž., Kondratov, R. V., Stark, G. R., Chumakov, P. M., & Gudkov, A. V. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.19.10309 · Cited by 173
Cyclin-dependent Kinases Are Inactivated by a Combination of p21 and Thr-14/Tyr-15 Phosphorylation after UV-induced DNA Damage
Poon, R. Y. C., Jiang, W. B., Toyoshima, H., & Hunter, T. R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.22.13283 · Cited by 172
Apoptosis in rheumatoid arthritis: p53 overexpression in rheumatoid arthritis synovium.
Firestein, G. S., Nguyen, K., Aupperle, K. R., Yeo, M., Boyle, D. L., & Zvaifler, N. J. (1996) · Europe PMC (PubMed Central) · Cited by 172
Loss of function of def selectively up-regulates Δ113p53 expression to arrest expansion growth of digestive organs in zebrafishPreprint
Chen, J., Ruan, H., Ng, S. M. E., Gao, C., Soo, H. M., Wu, W., Zhang, Z., Wen, Z., Lane, D. P., & Peng, J. (2005) · Genes & Development · doi:10.1101/gad.1366405 · Cited by 172
Mutations in the p53 and SCID genes cooperate in tumorigenesis.Preprint
Nacht, M., Strasser, A., Chan, Y. R., Harris, A. W., Schlissel, M. S., Bronson, R. T., & Jacks, T. (1996) · Genes & Development · doi:10.1101/gad.10.16.2055 · Cited by 172
p53 at the crossroad of DNA replication and ribosome biogenesis stress pathways
Lindström, M. S., Bártek, J., & Maya‐Mendoza, A. (2022) · Cell Death and Differentiation · doi:10.1038/s41418-022-00999-w · Cited by 177
Cancer progression and p53
Carson, D. A., & Lois, A. F. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91693-8 · Cited by 171
IgH Class Switch Recombination to IgG1 in DNA-PKcs-Deficient B Cells
Manis, J. P., Dudley, D. D., Kaylor, L., & Alt, F. W. (2002) · Immunity · doi:10.1016/s1074-7613(02)00306-0 · Cited by 170
Chronic myelogenous leukemia: mechanisms underlying disease progression
Shet, A. S., Jahagirdar, B., & Verfaillie, C. M. (2002) · Leukemia · doi:10.1038/sj.leu.2402577 · Cited by 169
Cutting Edge: TRAIL Deficiency Accelerates Hematological Malignancies
Zerafa, N., Westwood, J. A., Cretney, E., Mitchell, S., Waring, P., Iezzi, M., & Smyth, M. J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.9.5586 · Cited by 169
Roles of BRCA1 in DNA damage repair: a link between development and cancer
Deng, C. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg082 · Cited by 169
A Farnesyltransferase Inhibitor Induces Tumor Regression in Transgenic Mice Harboring Multiple Oncogenic Mutations by Mediating Alterations in Both Cell Cycle Control and Apoptosis
Barrington, R. E., Subler, M. A., Rands, E., Omer, C. A., Miller, P. J., Hundley, J. E., Koester, S. K., Troyer, D. A., Bearss, D. J., Conner, M. W., et al. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.1.85 · Cited by 169
Over-expression of Plk4 induces centrosome amplification, loss of primary cilia and associated tissue hyperplasia in the mouse
Coelho, P. A., Bury, L., Shahbazi, M. N., Liakath‐Ali, K., Tate, P. H., Wormald, S., Hindley, C. J., Huch, M., Archer, J., Skarnes, W. C., et al. (2015) · Open Biology · doi:10.1098/rsob.150209 · Cited by 168
Epigallocatechin-3-gallate induces apoptosis in estrogen receptor–negative human breast carcinoma cells via modulation in protein expression of p53 and Bax and caspase-3 activation
Roy, A. M., Baliga, M. S., & Katiyar, S. K. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.81.4.1 · Cited by 168
Mechanism-Based Cancer Prevention Approaches: Targets, Examples, and the Use of Transgenic Mice
Hursting, S. D., Slaga, T. J., Fischer, S. M., DiGiovanni, J., & Phang, J. M. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.3.215 · Cited by 168
Germ Line Transmission of the Cdk4R24C Mutation Facilitates Tumorigenesis and Escape from Cellular Senescence
Rane, S. G., Cosenza, S. C., Mettus, R. V., & Reddy, E. P. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.2.644-656.2002 · Cited by 167
Benzodiazepinedione inhibitors of the Hdm2:p53 complex suppress human tumor cell proliferation in vitro and sensitize tumors to doxorubicin in vivo
Koblish, H. K., Zhao, S., Franks, C. F., Donatelli, R. R., Tominovich, R. M., LaFrance, L. V., Leonard, K. A., Gushue, J. M., Parks, D. J., Calvo, R. R., et al. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0199 · Cited by 167
Genetic and Infectious Prion Diseases
Prusiner, S. B. (1993) · Archives of Neurology · doi:10.1001/archneur.1993.00540110011002 · Cited by 167
Mdm-2: “big brother” of p53
Momand, J. A., & Zambetti, G. P. (1997) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19970301)64:3 · Cited by 167
p53-dependent and p53-independent activation of apoptosis in mammary epithelial cells reveals a survival function of EGF and insulin.
Merlo, G. R., Basolo, F., Fiore, L., Duboc, L., & Hynes, N. E. (1995) · The Journal of Cell Biology · doi:10.1083/jcb.128.6.1185 · Cited by 167
The p53 Family Coordinates Wnt and Nodal Inputs in Mesendodermal Differentiation of Embryonic Stem Cells
Wang, Q., Zou, Y., Nowotschin, S., Kim, S. Y., Li, Q. V., Soh, C.-L., Su, J., Zhang, C., Shu, W., Xi, Q., et al. (2016) · Cell stem cell · doi:10.1016/j.stem.2016.10.002 · Cited by 166
Analysis of ku80-Mutant Mice and Cells with Deficient Levels of p53
Lim, D., Vogel, H. S., Willerford, D. M., Sands, A., Platt, K. A., & Hasty, P. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.11.3772-3780.2000 · Cited by 166
Calorie restriction delays spontaneous tumorigenesis in p53-knockout transgenic mice.
Hursting, S. D., Perkins, S. N., & Phang, J. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.15.7036 · Cited by 166
p53 binds single-stranded DNA ends through the C-terminal domain and internal DNA segments via the middle domain
Bakalkin, G. Y., Selivanova, G., Yakovleva, T., Владимировна, К. Е., Kashuba, E., Magnússon, K. P., Székely, L., Klein, G., Terenius, L. Y., & Wiman, K. G. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.3.362 · Cited by 166
A Phase I Study of Adenovirus-Mediated Wild-Type p53 Gene Transfer in Patients with Advanced Non-Small Cell Lung Cancer
Schüler, M., Rochlitz, C. F., Horowitz, J. A., Schlegel, J., Perruchoud, A. P., Kommoss, F., Bolliger, C. T., Kauczor, H., Dalquen, P., Fritz, M. A., et al. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.14-2075 · Cited by 166
The Central Nervous System-Restricted Transcription Factor Olig2 Opposes p53 Responses to Genotoxic Damage in Neural Progenitors and Malignant Glioma
Mehta, S. V., Huillard, E., Kesari, S., Maire, C. L., Golebiowski, D., Harrington, E. P., Alberta, J. A., Kane, M., Theisen, M., Ligon, K. L., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.01.035 · Cited by 165
Modeling Disease in Human ESCs Using an Efficient BAC-Based Homologous Recombination System
Song, H., Chung, S.-K., & Xu, Y. (2010) · Cell stem cell · doi:10.1016/j.stem.2009.11.016 · Cited by 165
Transgenic mouse model for studying the transcriptional activity of the p53 protein: age‐ and tissue‐dependent changes in radiation‐induced activation during embryogenesis
Gottlieb, E., Haffner, R., King, A., Asher, G., Gruss, P., Lonai, P., & Oren, M. (1997) · The EMBO Journal · doi:10.1093/emboj/16.6.1381 · Cited by 165
Isolation of 10 differentially expressed cDNAs in p53-induced apoptosis: activation of the vertebrate homologue of the drosophila seven in absentia gene.
Amson, R. B., Nemani, M., Roperch, J.-P., Israeli, D., Bougueleret, L., Gall, I. L., Medhioub, M., Linares‐Cruz, G., Lethrosne, F., Pasturaud, P., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.3953 · Cited by 165
The p53 tumor suppressor protein, a modulator of cell proliferation.
Ullrich, S. J., Anderson, C. W., Mercer, W. E., & Appella, E. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49524-0 · Cited by 165
To pop or not to pop: p53 as a critical modulator of tumour responsiveness to therapy in vivo?
Workman, P. (1995) · Human & Experimental Toxicology · doi:10.1177/096032719501400213 · Cited by 165
Identification of a progenitor cell of origin capable of generating diverse meningioma histological subtypes
Kalamarides, M., Stemmer-Rachamimov, A. O., Niwa‐Kawakita, M., Chareyre, F., Clermont, E., Han, Z.-Y., Martinelli, C., Lusis, E. A., Hegedűs, B., Gutmann, D. H., et al. (2011) · Oncogene · doi:10.1038/onc.2010.609 · Cited by 164
p53 Plays a Role in Mesenchymal Differentiation Programs, in a Cell Fate Dependent Manner
Molchadsky, A., Shats, I., Goldfinger, N., Pevsner‐Fischer, M., Olson, M., Rinon, A., Tzahor, E., Lozano, G., Zipori, D., Sarig, R., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003707 · Cited by 165
How aneuploidy affects metabolic control and causes cancer
Rasnick, D., & DUESBERG, P. H. (1999) · Biochemical Journal · doi:10.1042/bj3400621 · Cited by 164
Current understanding of the role and targeting of tumor suppressor p53 in glioblastoma multiforme
England, B., Huang, T., & Karsy, M. (2013) · Tumor Biology · doi:10.1007/s13277-013-0871-3 · Cited by 163
Involvement of p53 in cell differentiation and development
Almog, N., & Rotter, V. (1997) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(97)00012-7 · Cited by 163
Increased E2F1 activity induces skin tumors in mice heterozygous and nullizygous for p53
Pierce, A. M., Gimenez-Conti, I. B., Schneider‐Broussard, R., Martinez, L. A., Conti, C. J., & Johnson, D. G. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8858 · Cited by 163
Role of the tumor suppressor gene Brca1 in genetic stability and mammary gland tumor formation
Deng, C., & Scott, F. (2000) · Oncogene · doi:10.1038/sj.onc.1203269 · Cited by 163
Down‐regulation of wild‐type p53 activity interferes with apoptosis of IL‐3‐dependent hematopoietic cells following IL‐3 withdrawal.
Gottlieb, E., Haffner, R., von Rüden, T., Wagner, E. F., & Oren, M. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06390.x · Cited by 163
The specificity of p53 mutation spectra in sunlight induced human cancers
Daya–Grosjean, L., Dumaz, N., & Sarasin, A. R. (1995) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/1011-1344(95)07130-t · Cited by 162
Present state and future perspectives of using pluripotent stem cells in toxicology research
Wobus, A. M., & Löser, P. (2011) · Archives of Toxicology · doi:10.1007/s00204-010-0641-6 · Cited by 161
p53 is balancing development, differentiation and de-differentiation to assure cancer prevention
Molchadsky, A., Rivlin, N., Brosh, R., Rotter, V., & Sarig, R. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq101 · Cited by 161
The E3 ligase HACE1 is a critical chromosome 6q21 tumor suppressor involved in multiple cancers
Zhang, L., Anglesio, M. S., O’Sullivan, M. J., Zhang, F., Yang, G., Sarao, R., Nghiem, M. P., Cronin, S. J. F., Hara, H., Melnyk, N., et al. (2007) · Nature Medicine · doi:10.1038/nm1621 · Cited by 161
Expression of matrix metalloproteinase 1, matrix metalloproteinase 2, and matrix metalloproteinase 9 in carcinoma of the head and neck
Franchi, A., Santucci, M., Masini, E., Sardi, I., Paglierani, M., & Gallo, O. (2002) · Cancer · doi:10.1002/cncr.10916 · Cited by 161
The p53-induced Gene-6 (Proline Oxidase) Mediates Apoptosis through a Calcineurin-dependent Pathway
Rivera, A. M., & Maxwell, S. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504852200 · Cited by 161
Transcription, apoptosis and p53: catch-22
Schüler, M., & Green, D. R. (2005) · Trends in Genetics · doi:10.1016/j.tig.2005.01.001 · Cited by 161
The WT1 Wilms' tumor suppressor gene: How much do we really know?
Reddy, J. C., & Licht, J. D. (1996) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(95)00014-7 · Cited by 161
p53, Stem Cells, and Reprogramming: Tumor Suppression beyond Guarding the Genome
Spike, B. T., & Wahl, G. M. (2011) · Genes & Cancer · doi:10.1177/1947601911410224 · Cited by 160
Global Changes in Processing of mRNA 3′ Untranslated Regions Characterize Clinically Distinct Cancer Subtypes
Singh, P., Alley, T. L., Wright, S., Kamdar, S. J., Schott, W. H., Wilpan, R. Y., Mills, K. D., & Graber, J. H. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-2236 · Cited by 160
Database of mouse strains carrying targeted mutations in genes affecting biological responses to DNA damage Version 7
Friedberg, E. C., & Meira, L. B. (2005) · DNA repair · doi:10.1016/j.dnarep.2005.09.009 · Cited by 160
Dickkopf-1, an inhibitor of the Wnt signaling pathway, is induced by p53
Wang, J., Shou, J., & Chen, X. (2000) · Oncogene · doi:10.1038/sj.onc.1203503 · Cited by 160
High frequency of p53 mutations in ultraviolet radiation-induced murine skin tumors: evidence for strand bias and tumor heterogeneity.
Kanjilal, S., Pierceall, W. E., Cummings, K. K., Kripke, M. L., & Ananthaswamy, H. N. (1993) · PubMed · Cited by 160
Regulation of ES cell differentiation by functional and conformational modulation of p53
Sabapathy, K., Klemm, M., Jaenisch, R., & Wagner, E. F. (1997) · The EMBO Journal · doi:10.1093/emboj/16.20.6217 · Cited by 159
Should mutant TP53 be targeted for cancer therapy?
Wang, Z., Strasser, A., & Kelly, G. L. (2022) · Cell Death and Differentiation · doi:10.1038/s41418-022-00962-9 · Cited by 162
hTERT antagonizes p53-induced apoptosis independently of telomerase activity
Rahman, R., Latonen, L., & Wiman, K. G. (2004) · Oncogene · doi:10.1038/sj.onc.1208232 · Cited by 159
Apoptosis and mitotic cell death: their relative contributions to normal-tissue and tumour radiation response
West, C. (1997) · International Journal of Radiation Biology · doi:10.1080/095530097143716 · Cited by 159
Ser18 and 23 phosphorylation is required for p53‐dependent apoptosis and tumor suppression
Chao, C., Herr, D., Chun, J., & Xu, Y. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601167 · Cited by 158

Authors: Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A.
Affiliations: Baylor College of Medicine (US)
ORCID: Slagle, Betty L.
Butel, Janet S.
Bradley, Allan
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 1992-03
Volume: 356
Issue: 6366
Pages: 215-221
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/356215a0
OpenAlex: W2126679757
Cited by: 4,649
References: 48
Citations by year: 2026: 16 · 2025: 48 · 2024: 51 · 2023: 74 · 2022: 76 · 2021: 80 · 2020: 86 · 2019: 92 · 2018: 84 · 2017: 96 · 2016: 119 · 2015: 89 · 2014: 121 · 2013: 146 · 2012: 157
FWCI: 82.13
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
Keywords: p53, tumor suppressor, spontaneous tumors, carcinogenesis, embryonic development, mouse model, neoplasms
MeSH terms: Alleles, Animals, Base Sequence, Blastocyst, DNA, Exons, Female, Genetic Vectors, Heterozygote, Homozygote, Male, Mice, Inbred CBA, Mice, Inbred C57BL, Mice, Transgenic, Molecular Sequence Data, Mutation, Neoplasms, Experimental, RNA, Messenger, Stem Cells, Blotting, Southern, Polymerase Chain Reaction, Genes, p53, Tumor Suppressor Protein p53, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks